|
CA 15-3 (mean ± SE, n = 24)
|
CEA (mean ± SE, n = 24)
|
TPA (mean ± SE, n = 24)
|
---|
Patients with metastatic breast cancer
|
1552 ± 384 kU/La
|
559.7 ± 177 μg/La
|
2639 ± 657 U/La
|
Age-matched healthy females
|
14.4 ± 1.1 kU/L
|
3.1 ± 0.3 μg/L
|
56.8 ± 10.8 U/L
|
-
aSignificantly different from age-matched control concentration (p < 0.05). The serum samples were used to isolate DNA, which was used to calculate the sensitivity and specificity of six different primer designs against hypermethylated RASSF1A